Factors influencing hepatitis C virus sero-prevalence among blood donors in north west Pakistan

Journal of Public Health Policy

Volumn 29, Issue 2, 2008, Pages 207-225

  Khattak, Muhammad Naeem ^a,d   Akhtar, Saeed ^b   Mahmud, Sadia ^c   Roshan, Tariq Mahmood ^d  

^a SCHOOL OF HEALTH SCIENCES   (Malaysia)

^b KUWAIT UNIVERSITY   (Kuwait)

^c AGA KHAN UNIVERSITY   (Pakistan)

^d SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Blood donors; Blood transfusion; Hepatitis C; Public health

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD DONOR; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; HEALTH EDUCATION; HEPATITIS C; HUMAN; MALE; MIDDLE AGED; PAKISTAN; RISK FACTOR; SOCIOECONOMICS; STATISTICS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BLOOD DONORS; CROSS-SECTIONAL STUDIES; HEALTH EDUCATION; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; PAKISTAN; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS;

EID: 44849115733     PISSN: 01975897     EISSN: 1745655X     Source Type: Journal    
DOI: 10.1057/jphp.2008.7     Document Type: Article

References (43)

1. WHO. Hepatitis C; Fact sheet No. 164. 2000.
2. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341(8): 556-562.
3. Seef L. Natural history of hepatitis C. Hepatology. 1997;26(suppl 1): 21-8.
4. Yano M, Kumada H, Kage M, Ikeda K, Shimamatsu K, Inoue O, et al. The long-term pathological evolution of chronic hepatitis C. Hepatology. 1996;23(6):1334-40.
5. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology. 1997; 112(2):463-72.
6. Serfaty L, Aumaitre H, Chazouilleres O, Bonnand AM, Rosmorduc O, Poupon RE, et al. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology. 1998;27(5):1435-40.
7. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet. 1989; 2(8670):1004-6.
8. Read AE, Donegan E, Lake J, Ferrell L, Galbraith C, Kuramoto IK, et al. Hepatitis C in patients undergoing liver transplantation. Ann Intern Med. 1991;114(4):282-4.
9. Tong CY, Khan R, Beeching NJ, Tariq WU, Hart CA, Ahmad N, et al. The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellular carcinoma. Epidemiol Infect. 1996;117(2):327-32.
10. Hopf U, Moller B, Kuther D, Stemerowicz R, Lobeck H, Ludtke-Handjery A, et al. Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol. 1990; 10(1):69-76.
11. Delage G, Infante-Rivard C, Chiavetta JA, Willems B, Pi D, Fast M. Risk factors for acquisition of hepatitis C virus infection in blood donors: results of a case-control study. Gastroenterology. 1999;116(4):893-899.
12. Serfaty L, Giral P, Elghouzzi MH, Jullien AM, Poupon R. Risk factors for hepatitis C virus infection in hepatitis C virus antibody ELISA-positive blood donors according to RIBA-2 status: a case-control survey. Hepatology. 1993;17(2):183-7.
13. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ. The risk of transfusion-transmitted viral infections. The retrovirus epidemiology donor study. N Engl J Med. 1996;334(26):1685-90.
14. Donahue JG, Munoz A, Ness PM, Brown Jr. DE, Yawn DH, McAllister Jr. HA, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med. 1992;327(6):369-73.
15. Koerner K, Cardoso M, Dengler T, Kerowgan M, Kubanek B. Estimated risk of transmission of hepatitis C virus by blood transfusion. Vox Sang. 1998;74(4):213-6.
16. Wake DJ, Cutting WA. Blood transfusion in developing countries: problems, priorities and practicalities. Trop Doct. 1998;28(1):4-8.
17. Abdul Mujeeb S, Aamir K, Mehmood K. Seroprevalence of HBV, HCV and HIV infections among college going first time voluntary blood donors. J Pak Med Assoc. 2000;50(8):269-70.
18. Akhtar S, Moatter T, Azam SI, Rahbar MH, Adil S. Prevalence and risk factors for intrafamilial transmission of hepatitis C virus in Karachi, Pakistan. J Viral Hepat. 2002;9(4):309-14.
19. Kakepoto GN, Bhally HS, Khaliq G, Kayani N, Burney IA, Siddiqui T, et al. Epidemiology of blood-borne viruses: a study of healthy blood donors in Southern Pakistan. Southeast Asian J Trop Med Public Health. 1996;27(4):703-6.
20. Mujeeb SA. Unsafe injections: a potential source of HCV spread in Pakistan. J Pak Med Assoc. 2001;51(1):1-3.
21. Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, et al. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology. 2000;31(3):756-62.
22. Osmond DH, Padian NS, Sheppard HW, Glass S, Shiboski SC, Reingold A. Risk factors for hepatitis C virus seropositivity in heterosexual couples. JAMA. 1993;269(3):361-5.
23. Kim YS, Ahn YO, Kim DW. Familial clustering of hepatitis B and C viruses in Korea. J Korean Med Sci. 1994;9(6):444-9.
24. Bari A, Akhtar S, Rahbar MH, Luby SP. Risk factors for hepatitis C virus infection in male adults in Rawalpindi-Islamabad, Pakistan. Trop Med Int Health. 2001;6(9):732-8.
25. Luby SP, Qamruddin K, Shah AA, Omair A, Pahsa O, Khan AJ, et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiol Infect. 1997;119(3):349-56.
26. Rehman K, Khan AA, Haider Z, Shahzad A, Iqbal J, Khan RU, et al. Prevalence of seromarkers of HBV and HCV in health care personnel and apparently healthy blood donors. J Pak Med Assoc. 1996;46(7):152-4.
27. Akhtar S, Younus M, Adil S, Jafri SH, Hassan F. Hepatitis C virus infection in asymptomatic male volunteer blood donors in Karachi, Pakistan. J Viral Hepat. 2004;11(6):527-35.
28. Al-Bahrani A, Panhotra BR. Prevalence of HBsAG and ANTI-HCV antibodies in blood donors of the Al-Hasa Region of Saudi Arabia. Ann Saudi Med. 2001;21(3-4):234-5.
29. Narang A, Kar P, Chakravarty A. HCV infection in a north Indian hospital. Indian J Gastroenterol. 1993;12(4):156.
30. Srikrishna A, Sitalakshmi S, Damodar P. How safe are our safe donors? Indian J Pathol Microbiol. 1999;42(4):411-6.
31. WHO. Injection safety; Fact sheet No. 231. 2002.
32. Ashwath D, Latha C, Soudarssanane MB, Wyatt HV. Unnecessary injections given to children under five years. Indian J Pediatr. 1993; 60(3):451-4.
33. Khan AJ, Luby SP, Fikree F, Karim A, Obaid S, Dellawala S, et al. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bull World Health Organ. 2000; 78(8):956-63.
34. Thaver IH. Prescribing patterns of primary care providers in squatter areas of Karachi. J Pak Med Assoc. 1995;45(11):301-2.
35. Raglow GJ, Luby SP, Nabi N. Therapeutic injections in Pakistan: from the patients' perspective. Trop Med Int Health. 2001;6(1):69-75.
36. Werner BG, Grady GF. Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity. Ann Intern Med. 1982;97(3):367-9.
37. Malik IA, Ahmad N, Luqman M, Legters LJ, Khalil U, Zaheeruddin, et al. Hepatitis C as a cause of chronic liver disease in northern Pakistan. J Pak Med Assoc. 1992;42(3):67-8.
38. Mull DS, Mull JD. Insights from community-based research on child pneumonia in Pakistan. Med Anthropol. 1994;15(4):335-52.
39. Reeler AV. Injections: a fatal attraction? Soc Sci Med. 1990;31(10): 1119-1125.
40. Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of bloodborne pathogens: a review. Bull World Health Organ. 1999;77(10):789-800.
41. Wyatt HV. Mothers, injections, and poliomyelitis. Soc Sci Med. 1999;14(B):225-33.
42. Kiyosawa K, Sodeyama T, Tanaka E, Nakano Y, Furuta S, Nishioka K, et al. Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med. 1991;115(5):367-9.
43. Tumminelli F, Marcellin P, Rizzo S, Barbera S, Corvino G, Furia P, et al. Shaving as potential source of hepatitis C virus infection. Lancet. 1995;345(8950):658.